The PROTAC cocktail effectively decreases cell surface CD34 (Figure 4F), suppresses both primary and secondary colony formation (Figure 4G) and reduces the ratio of aldehyde dehydrogenase (ALDH) positive AML stem cells (Figure 4H,I). The gene discussed is CD34; the disease is acute myeloid leukemia.